Trends in androgen prescriptions from military treatment facilities: 2007 to 2011

Ross Canup, Kenneth Bogenberger, Selasi Attipoe, Donnamaria R. Jones, Cara H. Olsen, Mark Stephens, Patricia A. Deuster

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Introduction: The role of testosterone in health and quality of life has become increasingly visible and overtly marketed to the public. Some evidence suggests that testosterone levels in men may be low because of a variety of reasons, including stress and environmental exposures. Objective: This study examines trends in testosterone prescriptions dispensed by military treatment facilities (MTFs). Methods: We examined data from the Department of Defense Pharmacy Data Transaction Service to determine the nature of androgen prescriptions dispensed through MTFs from 2007 through 2011. Results: The number of androgen prescriptions increased more than two-fold across the military from 19,494 in 2007 to 45,270 in 2011. Most prescriptions (99%) were for men. Androgen prescription rates rose 23% per year from 2007 through 2011 (p < 0.001, CI 23-24%). The prescription rate for 35- to 44-year-olds increased more than any other age group, with annual increases averaging 33% (p < 0.001, CI 32-34%). Conclusion: The number of androgen prescriptions within MTFs rose significantly from 2007 through 2011. This is similar to rises in androgen prescriptions seen in civilian medical systems. Clinical indications for the sharp increase in testosterone prescriptions are unknown, and the indications for clinically appropriate testosterone replacement need further clarification.

Original languageEnglish (US)
Pages (from-to)728-731
Number of pages4
JournalMilitary Medicine
Volume180
Issue number7
DOIs
StatePublished - Jan 1 2015

Fingerprint

Military Facilities
Androgens
Prescriptions
Testosterone
Therapeutics
Environmental Exposure
Age Groups
Quality of Life

All Science Journal Classification (ASJC) codes

  • Public Health, Environmental and Occupational Health

Cite this

Canup, R., Bogenberger, K., Attipoe, S., Jones, D. R., Olsen, C. H., Stephens, M., & Deuster, P. A. (2015). Trends in androgen prescriptions from military treatment facilities: 2007 to 2011. Military Medicine, 180(7), 728-731. https://doi.org/10.7205/MILMED-D-14-00496
Canup, Ross ; Bogenberger, Kenneth ; Attipoe, Selasi ; Jones, Donnamaria R. ; Olsen, Cara H. ; Stephens, Mark ; Deuster, Patricia A. / Trends in androgen prescriptions from military treatment facilities : 2007 to 2011. In: Military Medicine. 2015 ; Vol. 180, No. 7. pp. 728-731.
@article{c1b9de7d44894828992644bac21ec2b7,
title = "Trends in androgen prescriptions from military treatment facilities: 2007 to 2011",
abstract = "Introduction: The role of testosterone in health and quality of life has become increasingly visible and overtly marketed to the public. Some evidence suggests that testosterone levels in men may be low because of a variety of reasons, including stress and environmental exposures. Objective: This study examines trends in testosterone prescriptions dispensed by military treatment facilities (MTFs). Methods: We examined data from the Department of Defense Pharmacy Data Transaction Service to determine the nature of androgen prescriptions dispensed through MTFs from 2007 through 2011. Results: The number of androgen prescriptions increased more than two-fold across the military from 19,494 in 2007 to 45,270 in 2011. Most prescriptions (99{\%}) were for men. Androgen prescription rates rose 23{\%} per year from 2007 through 2011 (p < 0.001, CI 23-24{\%}). The prescription rate for 35- to 44-year-olds increased more than any other age group, with annual increases averaging 33{\%} (p < 0.001, CI 32-34{\%}). Conclusion: The number of androgen prescriptions within MTFs rose significantly from 2007 through 2011. This is similar to rises in androgen prescriptions seen in civilian medical systems. Clinical indications for the sharp increase in testosterone prescriptions are unknown, and the indications for clinically appropriate testosterone replacement need further clarification.",
author = "Ross Canup and Kenneth Bogenberger and Selasi Attipoe and Jones, {Donnamaria R.} and Olsen, {Cara H.} and Mark Stephens and Deuster, {Patricia A.}",
year = "2015",
month = "1",
day = "1",
doi = "10.7205/MILMED-D-14-00496",
language = "English (US)",
volume = "180",
pages = "728--731",
journal = "Military Medicine",
issn = "0026-4075",
publisher = "Association of Military Surgeons of the US",
number = "7",

}

Canup, R, Bogenberger, K, Attipoe, S, Jones, DR, Olsen, CH, Stephens, M & Deuster, PA 2015, 'Trends in androgen prescriptions from military treatment facilities: 2007 to 2011', Military Medicine, vol. 180, no. 7, pp. 728-731. https://doi.org/10.7205/MILMED-D-14-00496

Trends in androgen prescriptions from military treatment facilities : 2007 to 2011. / Canup, Ross; Bogenberger, Kenneth; Attipoe, Selasi; Jones, Donnamaria R.; Olsen, Cara H.; Stephens, Mark; Deuster, Patricia A.

In: Military Medicine, Vol. 180, No. 7, 01.01.2015, p. 728-731.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Trends in androgen prescriptions from military treatment facilities

T2 - 2007 to 2011

AU - Canup, Ross

AU - Bogenberger, Kenneth

AU - Attipoe, Selasi

AU - Jones, Donnamaria R.

AU - Olsen, Cara H.

AU - Stephens, Mark

AU - Deuster, Patricia A.

PY - 2015/1/1

Y1 - 2015/1/1

N2 - Introduction: The role of testosterone in health and quality of life has become increasingly visible and overtly marketed to the public. Some evidence suggests that testosterone levels in men may be low because of a variety of reasons, including stress and environmental exposures. Objective: This study examines trends in testosterone prescriptions dispensed by military treatment facilities (MTFs). Methods: We examined data from the Department of Defense Pharmacy Data Transaction Service to determine the nature of androgen prescriptions dispensed through MTFs from 2007 through 2011. Results: The number of androgen prescriptions increased more than two-fold across the military from 19,494 in 2007 to 45,270 in 2011. Most prescriptions (99%) were for men. Androgen prescription rates rose 23% per year from 2007 through 2011 (p < 0.001, CI 23-24%). The prescription rate for 35- to 44-year-olds increased more than any other age group, with annual increases averaging 33% (p < 0.001, CI 32-34%). Conclusion: The number of androgen prescriptions within MTFs rose significantly from 2007 through 2011. This is similar to rises in androgen prescriptions seen in civilian medical systems. Clinical indications for the sharp increase in testosterone prescriptions are unknown, and the indications for clinically appropriate testosterone replacement need further clarification.

AB - Introduction: The role of testosterone in health and quality of life has become increasingly visible and overtly marketed to the public. Some evidence suggests that testosterone levels in men may be low because of a variety of reasons, including stress and environmental exposures. Objective: This study examines trends in testosterone prescriptions dispensed by military treatment facilities (MTFs). Methods: We examined data from the Department of Defense Pharmacy Data Transaction Service to determine the nature of androgen prescriptions dispensed through MTFs from 2007 through 2011. Results: The number of androgen prescriptions increased more than two-fold across the military from 19,494 in 2007 to 45,270 in 2011. Most prescriptions (99%) were for men. Androgen prescription rates rose 23% per year from 2007 through 2011 (p < 0.001, CI 23-24%). The prescription rate for 35- to 44-year-olds increased more than any other age group, with annual increases averaging 33% (p < 0.001, CI 32-34%). Conclusion: The number of androgen prescriptions within MTFs rose significantly from 2007 through 2011. This is similar to rises in androgen prescriptions seen in civilian medical systems. Clinical indications for the sharp increase in testosterone prescriptions are unknown, and the indications for clinically appropriate testosterone replacement need further clarification.

UR - http://www.scopus.com/inward/record.url?scp=84943576782&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84943576782&partnerID=8YFLogxK

U2 - 10.7205/MILMED-D-14-00496

DO - 10.7205/MILMED-D-14-00496

M3 - Article

C2 - 26126240

AN - SCOPUS:84943576782

VL - 180

SP - 728

EP - 731

JO - Military Medicine

JF - Military Medicine

SN - 0026-4075

IS - 7

ER -